Anxiety and Benzodiazepine Use in an Older Adult
Mr. K is a 75-year-old retired teacher with a history of generalized anxiety disorder since his 40s. He has been on alprazolam 1 mg three times daily for many years, prescribed by his previous physician. He presents with increased anxiety and insomnia after his wife died 3 months ago. He also has hypertension and osteoarthritis. He admits to occasional alcohol use (1-2 beers a week). His daughter is concerned about his memory and balance. On exam, he has mild gait instability and mild cognitive impairment (MoCA 23/30).
1. What are the risks of long-term benzodiazepine use in this patient, and how would you address them?
Read the worked answer
Long-term benzodiazepine use in older adults is associated with cognitive impairment, falls, fractures, motor vehicle accidents, and dependence. The Beers Criteria recommend avoiding benzodiazepines in the elderly. This patient has gait instability and cognitive impairment, which may be exacerbated by alprazolam. He also uses alcohol, increasing risk. The goal is to gradually taper the benzodiazepine while managing anxiety with safer alternatives. Abrupt discontinuation can cause withdrawal seizures, so a slow taper (e.g., reduce by 10-25% every 2-4 weeks) is necessary. Switch to a longer-acting benzodiazepine like clonazepam or diazepam to facilitate tapering? Actually, in the elderly, it's often better to taper the current drug slowly. But because alprazolam has a short half-life and is more prone to withdrawal, switching to an equivalent dose of diazepam (e.g., 1 mg alprazolam ≈ 10 mg diazepam) may help. However, diazepam has active metabolites and may accumulate. Alternatively, taper alprazolam slowly. Also, address grief and anxiety with psychotherapy (CBT), and consider an SSRI (e.g., escitalopram) as a safer long-term treatment. Educate the patient and family about the risks and the taper plan.
2. What nonpharmacologic and pharmacologic alternatives would you recommend for his anxiety and insomnia?
Read the worked answer
Nonpharmacologic: cognitive-behavioral therapy for anxiety and insomnia (CBT-I), relaxation techniques, sleep hygiene, grief counseling, and social support. Pharmacologic: SSRIs are first-line for GAD; escitalopram 5-10 mg daily or sertraline 25-50 mg daily. Start low and go slow. Avoid tricyclics due to anticholinergic effects. Buspirone is another option but may be less effective. For insomnia, avoid sedative-hypnotics (z-drugs) due to similar risks as benzodiazepines. Consider low-dose trazodone (25-50 mg) or melatonin. If using an SSRI, monitor for hyponatremia and GI effects. Also, address alcohol use: recommend reduction or cessation. Coordinate with his daughter for support and monitoring. Regular follow-up to assess anxiety, sleep, and taper progress.